Key facts
- Perimeter (Discovery Tools (Healthcare))’s last known valuation is $148.0M (Apr 2026).
- It has raised $60.0M; the latest was Early Stage VC ($60.0M) in Apr 2026.
- Notable investors include Goldcrest Capital, Kanders & Company, SCS Financial, Four Cities Capital, Safe Artificial Intelligence Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Perimeter (Discovery Tools (Healthcare))
- ·The full record, as it builds
Funding rounds
No funding rounds for Perimeter (Discovery Tools (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Perimeter (Discovery Tools (Healthcare))
Developer of biosecurity infrastructure and intelligence software designed to detect and analyze biological threats in real time. The company provides platforms that integrate biosurveillance data, sequencing, and analytics, enabling governments and healthcare systems to monitor pathogens and support response planning.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2026
- Website
- perimeter.bio/
- Ownership
- Privately Held (backing)
Perimeter (Discovery Tools (Healthcare)) doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Perimeter (Discovery Tools (Healthcare)) shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Perimeter (Discovery Tools (Healthcare)) in its N-PORT filings yet. We sweep new filings monthly.